Gert-Jan van de Geijn

Gert-Jan van de Geijn is a medical researcher at the University Medical Center Groningen's Faculty of Medical Sciences, Department of Internal Medicine. His work spans multiple clinical domains with significant contributions to rehabilitation engineering, diabetes research, and oncology.

His research interests focus on pulmonary rehabilitation for obese asthma patients, lipid metabolism in type 2 diabetes, and safety protocols in cancer therapies. Recent work includes investigating dapagliflozin's effects on postprandial lipids and evaluating testosterone-based dosing regimens in prostate cancer treatment.

His publication trends show strong emphasis on randomized controlled trials across diverse medical conditions, particularly in respiratory medicine, endocrinology, and oncology. Key themes include rehabilitation engineering, metabolic disorders, and rare disease data infrastructure development.

Collaborative work includes the SOLVE-RD Consortium's large-scale rare disease research infrastructure project presented at BioSB 2020. His research contributes to UN Sustainable Development Goals through medical advancements in chronic disease management.